Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple Sclerosis
Doc Wire News,
This article was originally published here Mult Scler J Exp Transl Clin. 2022 Feb 23;8(1):20552173211070752.
Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple Sclerosis
Overview of attention for article published in Multiple Sclerosis Journal – Experimental, Translational and Clinical, February 2022
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (66th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 16 Mendeley